274 results on '"Peng, Mingli"'
Search Results
2. Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccines
3. A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging
4. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota
5. The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels
6. Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
7. Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence
8. Low-frequency, exhausted immune status of CD56dim NK cells and disordered inflammatory cytokine secretion of CD56bright NK cells associated with progression of severe HFMD, especially in EV71-infected patients
9. A Potential Antiviral Role for CCR5+CD8+ T Cells in Children with Hepatitis B
10. Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China
11. Teaching Design of the Nernst Equation Based on the “Flipped Classroom” Method
12. Magnetic-responsive Pickering Emulsion Based on MFe2O4 (M=Mn, Fe, Co, Ni, Cu, Zn) for Green and Efficient Oxidation of Benzyl Alcohol
13. Magnetothermal regulation of in vivo protein corona formation on magnetic nanoparticles for improved cancer nanotherapy
14. Magnetic-responsive Pickering emulsions based on MFe2O4 (M = Mn, Fe, Co, Ni, Cu, Zn) for green and efficient oxidation of benzyl alcohol.
15. A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B.
16. Higher risk of disease progression in the grey zone relative to inactive Chronic hepatitis B
17. A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation?
18. Study of the Cold Curing Characteristics of Isocyanate-Modified Asphalt.
19. Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.
20. Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases
21. Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with Cirrhosis
22. Genotyping of Multiple Clinical Samples with a Combined Direct PCR and Magnetic Lateral Flow Assay
23. Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection
24. Dynamic immunogenicity after primary and booster inactivated SARS‐CoV‐2 vaccination in people living with HIV: A longitudinal observational study
25. Curc-mPEG454, a PEGylated Curcumin Derivative, Improves Anti-inflammatory and Antioxidant Activities: a Comparative Study
26. Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: a longitudinal observational study
27. Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
28. TDF Promotes Glycolysis and Mitochondrial Dysfunction to Accelerate Lactate Accumulation by Downregulating PGC1α in Mice
29. Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
30. Co‐ and Nd‐Codoping‐Induced High Magnetization in Layered MoS 2 Crystals
31. Risk of waning humoral responses after inactivated or subunit recombinant SARS‐CoV‐2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China
32. Additional file 3 of Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis
33. Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS‐CoV‐2 vaccination in patients with chronic hepatitis B virus infection
34. KMCP: accurate metagenomic profiling of both prokaryotic and viral populations by pseudo-mapping
35. A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging
36. Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
37. Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer
38. Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
39. Co‐ and Nd‐Codoping‐Induced High Magnetization in Layered MoS2 Crystals.
40. Association between immunosuppressants and antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
41. The Metal Ion Release of Manganese Ferrite Nanoparticles: Kinetics, Effects on Magnetic Resonance Relaxivities, and Toxicity
42. Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
43. Additional file 1 of Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence
44. Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors.
45. Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection
46. Design of Magnetic Nanoplatforms for Cancer Theranostics
47. Controllable Synthesis of Superparamagnetic Magnetic Iron Oxide Nanoparticles and Induction Heating Studies: A Comprehensive Chemistry Experiment
48. Effectiveness of Heterologous and Homologous COVID-19 Vaccine: A Systematic Review and Meta-Analysis
49. Dynamics of the gut-liver axis in rats with varying fibrosis severity
50. Characteristics of Circulating T Cell Receptor γδ T Cells from Individuals Chronically Infected with Hepatitis B Virus (HBV): An Association between $V_\delta 2$ Subtype and Chronic HBV Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.